网站大量收购独家精品文档,联系QQ:2885784924

Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy.doc

Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy

 PAGE \* MERGEFORMAT 8 Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy Authors: ZHOU Su-zhu, HUANG Guo-fu, Zhang Mujuan, Liang Wenyong Abstract [Objective] To observe locally advanced non-small cell lung cancer after conventional radiotherapy to the late-course accelerated hyperfractionated radiotherapy synchronization EP chemotherapy efficacy and adverse reactions. [Methods] (1) radiotherapy alone group of 80 cases of the first 2 / 3 courses of conventional radiotherapy 40Gy located around after 1 / 3 of course be changed after the shrinking wild-course accelerated hyperfractionation radiotherapy. (2) concurrent chemotherapy and radiotherapy group of 54 cases, while in the above was added 5-cycle EP regimen. [Results] concurrent chemotherapy and radiotherapy alone group and 1 year, 2 years, 3-year survival rates were 66.7% (36/54), 38.9% (21/54), 18.5% (10/54) and 41.3% (33 / 80), 16.2% (13/80), 7.5% (6 / 80), 2-year survival rate was significantly different (χ2 = 8.73, P lt;0.01), effective rates were 88.9% and 55.0% (χ2 = 16.849, P lt;0.01). [Conclusion] after conventional radiotherapy to the late-course accelerated hyperfractionated concurrent chemotherapy and radiotherapy can improve local control rate and survival rate. Keywords: non-small cell lung cancer 1 Materials and methods 1.1 Case Selection A total of 134 cases of two groups of non-small cell lung cancer patients were confirmed by pathology or cytology. According to international TNM staging criteria, stage of disease for stage Ⅲ ~ Ⅳ, of which 81 cases of stage Ⅲ, Ⅳ period of 53 cases; pathological types: squamous cell carcinoma 78 cases, 30 cases of adenocarcinoma, squamous carcinoma 26 cases; aged 19 years ~ 74. Male 85 cases, female 49 cases. Karnofsky score 50 to 90 minutes, with an average of 71.4 points; tumor location: central type in 97 cases, 37 cases of periphera

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档